Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mitchell Horwitz, MD
Duke University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
52 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Instituto Nacional de Câncer José Alencar Gomes Da Silva - Inca
Rio de Janeiro, Rio de Janeiro, Brazil
- Hospital Das Clínicas Da Faculdade de Medicina Da Universidade de São Paulo
São Paulo, São Paulo, Brazil
- Hospital Das Clínicas Da Faculdade de Medicina Da Universidade de São Paulo Pediatrics
São Paulo, São Paulo, Brazil
- Hospital Das Clínicas Da Faculdade de Medicina de Ribeirão Preto Da Universidade de São Paulo
São Paulo, São Paulo, Brazil
- Hospital Israelita Albert Einstein
São Paulo, Brazil
- Robert Debré
Paris, France
- Rambam
Haifa, Israel
- Hadassah Medical Center
Jerusalem, Israel
- Rabin Medical Center, Beilinson Hospital
Petah Tikva, Israel
- Dana-Dwek Children'S Hospital, Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
- Tel-Aviv Sourasky Medical Center
Tel Aviv, Israel
- Chaim Sheba Medical Center, the Edmond and Lily Safra Children'S Hospital
Tel Litwinsky, Israel
- Careggi University Hospital
Florence, Italy
- Ospedale Pediatrico Bambino Gesù
Rome, Italy
- Prinses Maxima Centrum Voor Kinderoncologie B.V.
Utrecht, Netherlands
- University Medical Center Utrecht
Utrecht, Netherlands
- Instituto Português de Oncologia de Lisboa Francisco Gentil
Lisbon, Portugal
- National University Cancer Institute
Singapore, Singapore
- Singapore General Hospital
Singapore, Singapore
- Hospital Universitari Vall D'Hebron Pediatrics
Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Ico Bellvitge
Barcelona, Spain
- Sant Joan de Deu
Barcelona, Spain
- University Hospital Vall D'Hebron
Barcelona, Spain
- Hospital Universitario Virgen del Rocío
Seville, Spain
- Hospital Universitario la Fe
Valencia, Spain
- Hospital Universitario Y Politécnico la Fe (pediatric)
Valencia, Spain
- the Royal Marsden Nhs Foundation Trust
Sutton, Surrey, United Kingdom
- Queen Elizabeth Hospital
Birmingham, United Kingdom
- St James Hospital
Leeds, United Kingdom
- Manchester University Nhs Foundation Trust
Manchester, United Kingdom
- City of Hope
Los Angeles, California, United States
- Ucla
Los Angeles, California, United States
- Stanford University Cancer Institute
Palo Alto, California, United States
- Uc San Diego Moores Cancer Center
San Diego, California, United States
- Children'S Hospital Colorado
Denver, Colorado, United States
- Northwestern University
Evanston, Illinois, United States
- Loyola University, Cardinal Bernardin Cancer Center
Maywood, Illinois, United States
- University of Kansas Cancer Center
Westwood, Kansas, United States
- the University of Maryland Medicine Center
Baltimore, Maryland, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Dec 2016
- Primary completion
- 29 Apr 2021
- Completion
- 7 Feb 2025
- Last update posted
- 25 Feb 2026
- Registered enrollment
- 125
- Registry id
- NCT02730299
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.